FUNDAMENTALS OF MS CARE – PART 3: CURRENT AND EMERGING THERAPIES AND SYMPTOM MANAGEMENT
Session 3 of Fundamentals offers an insight into multidisciplinary considerations to include DMTs, practical nursing approaches to...
OPTIMIZING MS TREATMENT: WHAT YOUR MS CLINIC IS MISSING
The course will focus on the many ways in which the addition of a clinical pharmacy specialist to the Neurology interdisciplinary team can...
Regional MS Summit to Improve Access to High Quality MS Care
Background: In 2006, the Greater Northwest Healthcare Provider Council (HPC) of the National Multiple Sclerosis Society (NMSS) identified a...
The Multiple Sclerosis at Home Access Program (MAHA): New Challenges for Those Living with Multiple Sclerosis and Significant Disability during the COVID-19 Pandemic
Background: Abundant evidence supports disparity in health care delivery for persons with disability. These disparities may be magnified...
Improving MS Care through Educational Outreach to Generalists
Background: People with multiple sclerosis (MS) need expert, comprehensive care. However, many people with MS receive care from generalist...
Diving into Complex Durable Medical Equipment Needs: The Multiple Sclerosis at Home Access Program (MAHA)
Background: Updated prevalence estimates indicate that nearly 1 million Americans are living with MS including a large cohort of aging...
Integrated Clinic-Based Pharmacist Impact on Time to Fingolimod Treatment Initiation
Background: Multiple Sclerosis (MS) has no cure and causes irreversible damage to the brain and spinal cord leading to physical and...
Evaluation of a 6 Week Integrative Medicine Workshop Series on Quality of Life, Self-Efficacy and Wellness in MS
Background: MS care provided in a comprehensive MS center improves outcomes. Well-established MS centers struggle to include complementary...